Links To And Excerpts From The American Academy Of Pediatrics 2021 Guidelines “Evaluation and Management of Well-Appearing Febrile Infants 8 to 60 Days Old”

Posted on September 5, 2022 by Tom Wade MD

In this post, I link to and excerpt from the American Academy of Pediatrics 2021 Guidelines “Evaluation and Management of Well-Appearing Febrile Infants 8 to 60 Days Old” [PubMed Abstract] [Full-Text HTML] [Full-Text PDF]. Pediatrics. 2021 Aug;148(2):e2021052228.

Erratum in

Abstract

This guideline addresses the evaluation and management of well-appearing, term infants, 8 to 60 days of age, with fever ≥38.0°C. Exclusions are noted. After a commissioned evidence-based review by the Agency for Healthcare Research and Quality, an additional extensive and ongoing review of the literature, and supplemental data from published, peer-reviewed studies provided by active investigators, 21 key action statements were derived. For each key action statement, the quality of evidence and benefit-harm relationship were assessed and graded to determine the strength of recommendations. When appropriate, parents’ values and preferences should be incorporated as part of shared decision-making. For diagnostic testing, the committee has attempted to develop numbers needed to test, and for antimicrobial administration, the committee provided numbers needed to treat. Three algorithms summarize the recommendations for infants 8 to 21 days of age, 22 to 28 days of age, and 29 to 60 days of age. The recommendations in this guideline do not indicate an exclusive course of treatment or serve as a standard of medical care. Variations, taking into account individual circumstances, may be appropriate.

Comment in

There are 25 similar articles in PubMed Central.

Evaluation and Management of Well-Appearing Febrile Infants 8 to 60 Days Old has been cited by:

Cited by

See all “Cited by” articles
This entry was posted in American Academy Of Pediatrics, Guidelines, Neonatology, Pediatrics. Bookmark the permalink.